9,122 trials (keyword fallback)
Acute Undifferentiated Leukemia · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities · Adult Acute Myeloid Leukemia With Del(5q)
Primary: Treatment Related Mortality Defined as the Percent of Patients no Longer Alive at 60 Days After Registration — 91; 10 Participants
GERD
Primary: Number of Participants Achieving at Least a 50% Improvement in the Gastroesophageal Reflux Disease Health-related Quality of Life Index (GERD-HRQL) From Baseline to 12…
Arm Lymphedema · Truncal Lymphedema · Breast Cancer
Primary: Arm Volume at End of Study — 2376.52; 2539.93 ml
Fluid Retention Tissue
Primary: Difference in Correlation of Thoracic Impedance With Ultra-filtration Volume (UFV) Between uCor and ZOE — 0.66; 0.23 difference in correlation coefficients
Acute Lung Injury (ALI) · ARDS
Primary: Feasibility of EIT Monitoring in This Population of ARDS/ALI Patients — 13 Patients successfully monitored with EIT
Obesity
Primary: Comparison of Body Fat Percentage Estimates to DXA References Classified by Body Mass Index — 2.50; 6.36; 5.75; 7.66 Total Body Fat Percentage
Congenital Heart Disease
Primary: Mean Difference in Stroke Volume Between CMR and SMIC — 1.7 ml — p=0.47
Cardiac Arrest · Sudden Cardiac Death
Primary: Mean Systolic and Diastolic Blood Pressures — 80.38; 121.21; 61.37; 15.52 mmHg
Congestive Heart Failure · Arrhythmias
Primary: Number of Positive Twave Studies and Concurrent Positive Optivol Measurement — 1; 1; 2; 5 participants
Eosinophilic Esophagitis
Primary: Esophageal Mucosal Impedance (MI) — 1457; 3463; 4225; 1713 Ohms
Heart Failure
Primary: Comparison of Reveal LINQ™ Subcutaneous Impedance (Units of Ohms) With Pulmonary Artery Pressure (Units of mmHg) From a Swan-Ganz Catheter During Right Heart…
GERD
Primary: Number of Impedance Episodes Following PPI and Placebo — 47; 53 number of episodes
Gastrointestinal Inflammation Associated With CVID · CVID Enteropathy
Primary: Number of Participants With Increase in Infection or Serious Adverse Events (SAEs) Related to Single Dose Administration of Ustekinumab — 0 participants
Body Composition
Primary: Percent Body Fat — 20.3; 20.4; 32.8; 33.4 percent body fat — p=0.001
Neonatal Brachial Plexus Palsy
Primary: Intrarater Reliability of Implicit Finger Length Estimates Using the HandUZ Device — 0.91; 0.92 Intraclass Correlation Coefficient